Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 03, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Present at 10th Annual JMP Securities Research Conference

SALT LAKE CITY, May 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that Adrian...
April 28, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Hold Conference Call to Discuss Fiscal Third Quarter 2011 Financial Results

SALT LAKE CITY, April 28, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced it will...
April 05, 2011 08:00 ET | Source: Myrexis, Inc.

Myrexis Presents Data on Hsp90 Inhibitor Program at 102nd AACR Annual Meeting

Potential for Combination With Other Targeted Cancer Therapies Prodrug With Improved Characteristics Demonstrates Equivalent Efficacy Evidence of Biological Activity in Patients SALT LAKE...
April 05, 2011 08:00 ET | Source: Myrexis, Inc.

Myrexis Presents Data on Cancer Metabolism Inhibitor Program at 102nd AACR Annual Meeting

SALT LAKE CITY, April 5, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced it...
March 29, 2011 12:15 ET | Source: Myrexis, Inc.

Myrexis Reorganizes to Align Resources With Current Pipeline

SALT LAKE CITY, March 29, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced a...
March 17, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Provide Update on Heat Shock Protein 90 and Cancer Metabolism Inhibitor Programs at 102nd Annual Meeting of American Association for Cancer Research

SALT LAKE CITY, March 17, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
March 16, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Present at 10th Annual Needham Healthcare Conference

SALT LAKE CITY, March 16, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
February 09, 2011 16:15 ET | Source: Myrexis, Inc.

Myrexis Reports Second Quarter Fiscal 2011 Financial Results

AzixaTM Two-Arm Phase 2b Study in Glioblastoma Initiated Conference Call Today at 4:30pm EST Upcoming Events Report Phase 2 monotherapy results in recurrent glioblastoma multiforme (GBM)...
February 03, 2011 09:00 ET | Source: Myrexis, Inc.

Myrexis Announces Azixa(TM) Clinical Data Publications

Phase 1 Clinical Data Published by Molecular Cancer Therapeutics Pre-Clinical, Phase 1 and 2 Clinical Data Review Published by Drugs of the Future SALT LAKE CITY, Feb. 3, 2011 (GLOBE NEWSWIRE)...
February 01, 2011 09:00 ET | Source: Myrexis, Inc.

Myrexis to Hold Conference Call to Discuss Fiscal Second Quarter 2011 Financial Results

SALT LAKE CITY, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right